Dental Bone Graft Substitute Market was valued at US$ 533.5 million in 2022 and is expected to reach US$ 1,011.2 million by 2030; it is estimated to record a CAGR of 8.3% from 2022 to 2030

The increasing burden of periodontal diseases and oral cancer, and the growing demand for dental cosmetic procedures bolster the dental bone graft substitute market size. However, the limitations and misconceptions associated with reimbursement policies hinder the dental bone graft substitute market growth.

Digitalization of Dentistry with CAD/CAM Technology act as Trend Dental Bone Graft Substitute Market Growth

Computer-aided design (CAD) and computer-aided manufacturing (CAM) are among the software techniques that help dentists perform complex procedures with accelerated pace, greater accuracy, and lesser effort. The benefits of CAD/CAM systems include user-friendly operations, digital impressions, single-visit treatments, improved patient safety, and long-lasting restorations. Moreover, digital dentistry with the integration of CAD/CAM enhances the productivity and profitability of a dental practice. Advancements in digital technologies for dentistry have enabled physicians to improve patient care by drastically reducing the time required for the restorative phase of treatment. CAD software also facilitates the digital designing of dental appliances, and CAM software aids in the manufacturing of the designed products. The accuracy and dependability of modern manufacturing processes and 3D scanning have further led to the reliable manufacturing of dental objects. The CAD/CAM technology can be used for the milling of customized block grafts of xenogeneic, allogeneic, and alloplastic origins. The technology also enables the customized production of allogeneic bone blocks for complex ridge augmentation procedures. Thus, the use of CAD/CAM technology in dentistry is emerging as a notable trend in the dental bone graft substitute market.

Technological developments make it easier for dentists to do their job quickly, safely, and comfortably. Technologically advanced instruments make dental hygiene appointments much more pleasant for patients than they used to be. As a result, patients become compliant and willingly schedule treatment and recall visits. Restorative dentistry benefits overall oral health, specifically facial appearance, along with effective teeth and oral care. Using new dental implantation techniques, as well as advanced navigation and monitoring technologies, dentists can insert implants through minimally invasive surgeries. Further, augmented reality (AR) technology is more prevalent in reconstructive and aesthetic procedures in dental practices, as it can simulate a realistic digital preview of how patients can look post treatment. Also, the increasing adoption of synthetic bone substitutes is likely to favor the growth of the US dental bone graft substitute market. For example, in 2020, Orthopediatrics Corp., a company focused solely on pediatric orthopedics, launched QuickPack, an all-synthetic replacement containing a high-viscosity calcium phosphate cement that mimics the mineral phase of natural bone. In July 2020, Spine Wave Inc. announced the successful launch of tempest allograft bone matrix. The tempest allograft bone matrix comprises cancellous and partially demineralized cortical bone. Such technological developments in dental bone graft substitutes are expected to provide opportunities for the dental bone graft substitute market growth in the coming years.

North America held the largest share of the global dental bone graft substitute market in 2022 owing to the increasing technological advancements, rising number of dental diseases and disorders, presence of geriatric population, and a significantly high number of key market players involved in new and existing product developments. However, Asia Pacific is predicted to register the highest CAGR during 2022–2030. The US held the largest share of the dental bone graft substitute market in North America in 2022. Market players in the US are adopting organic and inorganic strategies for dental bone graft substitute market development. For instance, in September 2021, Straumann Group announced a strategic partnership with Aspen Dental Management, Inc. (ADMI) to provide dental implant solutions, abutments, and CAD/CAM options to more than 1,000 ADMI and affiliated workplaces throughout 45 US states. As a part of the agreement, Straumann Group will supply Aspen Dental-supported and ClearChoice-supported independent practices with a wide variety of dental implants and CAD/CAM solutions. Furthermore, in January 2021, Nobel Biocare invited dental practitioners to join the Mucointegration era by introducing the Xeal and TiUltra surfaces in the US. These novel surfaces are used on implants and abutments to improve tissue integration at every level. Thus, the factors mentioned above support the market growth. Substantial increase in oral condition, implementation of strategic policies by market players, and higher awareness about the utilization of dental consumables represent the considerable market share and growth of Canada’s dental consumables market. According to a study published by Smile Montreal Dentistry in 2020, around 98% of Canadians encounter some or the other kind of oral condition once in their lifetime. Moreover, according to the study published by the Canadian Dental Association, around 7 out of 10 Canadian suffer from some form of gum disease. Thus, the growing number of dental problems in North America is fueling the growth of the dental bone graft substitute market.

Dental Bone Graft Substitute Market: Competitive Landscape and Key Developments

Dentsply Sirona Inc, Dentium Co Ltd, Geistlich Pharma AG, ZimVie Inc, Keystone Dental Inc, Straumann Holding AG, Medtronic Plc, BioHorizons Inc, MEDOSIS, and LifeNet Health Inc. are a few key companies operating in the dental bone graft substitute market. Market players adopt product innovation strategies to meet evolving customer demands, thereby maintaining their brand names in the dental bone graft substitute market.

A few of the recent developments in the global dental bone graft substitute market are mentioned below:

• In October 2022, Geistlich Pharma announced the acquisition of Lynch Biologics, LLC. The acquisition helped Geistlich Pharma to strengthen its portfolio by adding Lynch Biologics, LLC’s leading product GEM 21S, which is based on a growth factor that accelerates bone formation and wound healing. The companies have aimed to advance new regenerative technologies in dentistry.